Page 5 - அண்டர்ரைட்டர் விருப்பம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அண்டர்ரைட்டர் விருப்பம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அண்டர்ரைட்டர் விருப்பம் Today - Breaking & Trending Today

Vancouver biotech company AbCellera's IPO nets $556M

Headquartered on Yukon Street in Olympic Village, AbCellera has come to national attention for its work developing potential antibody treatments for COVID-19.
Antibodies are proteins produced naturally by the body’s white blood cells that latch onto viruses, bacteria, and other infectious microbes and neutralize them. Antibodies are unique for each pathogen, and it takes the body time (usually a few days) to build antibodies suited for a novel infection.
AbCellera looked at blood from COVID-19 survivors to find ones that might be useful for patients fighting the disease.
It received $175 million in federal funding earlier this year to aid its search, and in November one of its treatments called bamlanivimab developed with US partner Eli Lilly received emergency approval from Health Canada for use in patients age 12 and up. ....

British Columbia , Eli Lilly , Abcellera Abcellerabio , Health Canada , Yukon Street , Olympic Village , Cellera Announces Closing , Initial Public Offering , Underwriter Option , Purchase Additional Shares , பிரிட்டிஷ் கொலம்பியா , எலி லில்லி , ஆரோக்கியம் கனடா , யூகோன் தெரு , ஒலிம்பிக் கிராமம் , ஆரம்ப பொது பிரசாதம் , அண்டர்ரைட்டர் விருப்பம் , கொள்முதல் பங்குகள் ,

NANOBIOTIX Announces Pricing of Global Offering and Approval to List on NASDAQ Global Select Market

NANOBIOTIX (Paris:NANO) (Euronext: NANO – ISIN : FR0011341205 – the ‘‘
Company’’), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the pricing of its initial public offering on the Nasdaq Global Select Market by way of a capital increase of 7,300,000 new ordinary shares (the “
New Shares”), consisting of a public offering of 5,445,000 ordinary shares in the form of American Depositary Shares (“
ADSs”), each representing the right to receive one ordinary share, in the United States (the “
U.S. Offering”) and a concurrent offering of 1,855,000 ordinary shares in certain jurisdictions outside of the United States to certain investors (the “ ....

New York , United States , France General , United Kingdom , Nord Pas De Calais , Republic Of France , Scott Stachowiak , Gilbert Dupont , Porter Novelli , Baillie Gifford , Enregistrement Universel , Nanobiotix Immuno , Ricky Bhajun , Brandon Owens , Pierre Louis Germain , Communications Department , Investor Relations Department , Exchange Commission , Prospectus Department , European Central Bank On , Evercore Group , Regulatory News , Nasdaq Global Select Market , American Depositary Shares , New Share , European Central Bank ,